Michael Lewis

President chez BioDiligence Partners, Inc.

Profil

Michael E.
Lewis is the founder of Adolor Corp.
(1994), Cephalon, Inc. (1988), Arena Pharmaceuticals, Inc. (1997), and CARA Therapeutics, Inc. (2004).
He is currently a Director at PolyMedix Pharmaceuticals, Inc. (since 2002) and President at BioDiligence Partners, Inc. (since 1994).
He previously held positions as Director at Incara Pharmaceuticals Corp., Vice President-Research at Message Pharmaceuticals, Inc., Senior Director-Scientific Affairs at Cephalon, Inc., Director at Arena Pharmaceuticals, Inc., and Director & Chief Scientific Advisor at CARA Therapeutics, Inc. He also served as an Independent Director at PolyMedix, Inc. (2005-2013) and Aeolus Pharmaceuticals, Inc. (2011-2013).
Dr. Lewis received his undergraduate degree from George Washington University and his graduate and doctorate degrees from Clark University.

Postes actifs de Michael Lewis

Sociétés	Poste	Début
PolyMedix Pharmaceuticals, Inc.	Directeur/Membre du Conseil	01/08/2002
BioDiligence Partners, Inc.	President	01/01/1994

Anciens postes connus de Michael Lewis

Sociétés	Poste	Fin
AEOLUS PHARMACEUTICALS, INC.	Directeur/Membre du Conseil	08/05/2013
POLYMEDIX, INC.	Directeur/Membre du Conseil	29/03/2013
Incara Pharmaceuticals Corp.	Directeur/Membre du Conseil	09/08/2004
ARENA PHARMACEUTICALS	Fondateur	01/01/2000
Adolor Corp.	Fondateur	-